Cantor Fitzgerald Reiterates Overweight on Tenet Healthcare, Maintains $104 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating on Tenet Healthcare (NYSE:THC) with a maintained price target of $104.

April 10, 2024 | 2:31 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating on Tenet Healthcare with a maintained price target of $104.
The reiteration of an Overweight rating and the maintenance of a $104 price target by a reputable analyst could signal confidence in Tenet Healthcare's future performance. This positive outlook is likely to influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100